Bram Goorden

Bram Goorden is a strategic life sciences executive and CEO with a robust background in building organizations and leading companies to maximize shareholder value through growth, innovation, and financial strategies.

He has been part of 3 company scale-ups, several start-ups, and has led 1 IPO, demonstrating his commitment to advancing healthcare and making a positive impact on patients.

Bram Goorden's education includes studies at prestigious institutions such as Harvard Business School, Northwestern University - Kellogg School of Management, University of Antwerp, Alma Mater Studiorum – Università di Bologna, and Thomas More University of Applied Sciences, covering a broad range of subjects from strategic negotiations to engineering and economics.

His professional journey includes executive roles at notable organizations such as IXICO, Oncobit AG, Mantis Photonics AB, VirdisGroup, Eagle Genomics, SOPHiA GENETICS, Foundation Medicine, Nestlé Health Science, UCB, Eli Lilly and Company, and Accenture, where he has contributed significantly in various capacities from CEO to Board Observer to Strategy Management Consultant.